Q92AX9 AF NFT

5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid723f2y6x5vkeiuuqvv6narc4ioi74kh4aplwefk4rcuev5apl2e/metadata.json
IPFS of structure file: 
bafybeiabgyuhb43c7jy7tk4yp4ztyljjlzysf4k7ff4646yxnp62mnqiqq/AF-Q92AX9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
First NFT owner address (bech32): 
genesis1rm22dz6qzyc5wv9da9mt26k5egsm2nwdw6hzk8
Current NFT ID #230980 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
230980
Accession (UniProt):
Q92AX9
Name::
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
Experimental Method:
Predicted structure
Sequence source:
LISTERIA INNOCUA SEROVAR 6A (STRAIN ATCC BAA-680 / CLIP 11262)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q92AX9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q92AX9|METE_LISIN 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase OS=Listeria innocua serovar 6a (strain ATCC BAA-680 / CLIP 11262) OX=272626 GN=metE PE=3 SV=1 MVKAISSNLGYPRLGEKREWKRALEKFWNGAISEEELLAETKALRLHALKKQQDKGIDLIPVGDFSFYDQVLDTSVTFGIIPKRFQHDGGKVSLNTYFDIARGKSDAVASEMTKWFNTNYHYIVPELAEADPKVLDNRALYYYEEAKNELGIEGKPVLVGPVTYLKLGKGSDAESFEILLDKFIPAYIEILKELETAGATWVQIDEPYLATSFDKKEIALFEKVYKAFHDAVPNLKIELQTYFESLDYYEEVVNLPVAAVGIDFVHDHGDSIKALKAHGFPQNKYLAAGVIDGRNVWRSDLDAKLALLTDIAHYVAEDKLIVQPSNSLLHVPVTKLSEPDLDEVILGGLSFADQKLDEIAILTKALTEGAESVAAELNEAREAVKALNESSHRNNLEVQAAIANLENVRVDRELPFAERIKLQHEWLKLPLFPTTTIGSFPQSPEVRKTRADWLKGNITDAEYNAFIEKETARWIKIQEDLDIDVLVHGEFERTDMVEYFGQKLAGFQATKFGWVQSYGSRAVRPPLIYGDVAFTEEITVKESVYAQSLTKRPVKGMLTAPVTIINWSFVRDDVPESVVANQVGLALRKEVEALERNGIKVIQVDEPALREGLPLKQARWQKYLDDAVYSFKLTTASVQNDTQIHTHMCYSDFDDIIDTISALDADVISIETSRSHGEIISTFEEVTYDKEIGLGVYDIHSPRVPTVSEIQDNIRRALRAIDAKQFWINPDCGLKTRKEPETIAALQDMIKATKEVRAEYQVLEK